What is the recommended dose of Mucinex (Guaifenesin) for treating chest congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Mucinex (Guaifenesin) for Chest Congestion

The recommended dose of Mucinex (guaifenesin) for treating chest congestion is 200-400 mg every 4 hours for immediate-release formulations, or 600-1200 mg every 12 hours for extended-release formulations, with a maximum daily dose of 2400 mg. 1, 2

Dosage Forms and Administration

Immediate-Release Formulation

  • 100 mg per 5 mL (1 teaspoonful) of liquid formulation 1
  • Recommended dosing: 200-400 mg (2-4 teaspoons) every 4 hours 3
  • Maximum of 6 doses (2400 mg) in 24 hours 3

Extended-Release Formulation

  • Available as 600 mg tablets 2
  • Recommended dosing: 1200 mg (two 600 mg tablets) every 12 hours 4
  • Extended-release formulation provides convenient 12-hour dosing compared to 4-hour dosing of immediate-release formulation 2
  • Can be taken with or without food, though food may delay peak concentration (Tmax) 2

Mechanism of Action

  • Guaifenesin acts as an expectorant by loosening mucus in the airways 3
  • Makes coughs more productive by improving mucociliary clearance 2
  • Helps relieve chest congestion associated with upper respiratory tract infections 4

Clinical Evidence

  • Extended-release guaifenesin has been shown to be bioequivalent to corresponding doses of immediate-release guaifenesin 2
  • Studies demonstrate that steady-state exposures are equivalent between 1,200 mg extended-release guaifenesin every 12 hours and 400 mg immediate-release guaifenesin every 4 hours 2
  • Clinical pharmacology and patient studies support the clinical utility of guaifenesin in respiratory conditions where mucus hypersecretion is prevalent 3

Safety Profile

  • Guaifenesin has a well-established and favorable safety and tolerability profile in adult and pediatric populations 3
  • In a study of 552 adults with URTI symptoms taking extended-release guaifenesin 1200 mg every 12 hours for 7 days, all adverse events were mild in severity with no serious adverse events reported 4
  • Most common adverse events include gastrointestinal effects, nervous system effects, and skin reactions 4

Important Considerations

  • Guaifenesin should not be used in combination with cough suppressants like dextromethorphan if there is a risk of increased airway obstruction 5
  • If symptoms persist beyond 7 days or are accompanied by fever, consult a healthcare provider 3
  • Adequate hydration should be maintained while taking guaifenesin to help thin mucus secretions 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.